Abstract:Chemical investigation of the mangrove‐derived fungus Trichoderma sp. GXT‐22.1 led to isolation and identification of 10 secondary metabolites, including one new compound, 5'‐(4‐methoxyphenyl)‐1',3'‐oxazole (1), one new natural compound, (E)‐6,10‐dimethyl‐5‐undecene‐2,9,10‐triol (2), along with eight known compounds, tricholumin A (3), harzianol J (4), cyclonerodiol (5), 10,11‐dihydro‐11‐hydroxycyclonerodiol (6), cyclonerodiol B (7), epicyclonerodiol oxide (8), cyclo(Val‐Pro) (9), and cyclo‐(4‐hydroxyprolinyl‐leucine) (10). The structural feature of oxazole in 1 was unusually found among the fungal metabolites. Compounds 1 and 4 exhibited weak cytotoxicity toward HepG2 and MCF‐7 human carcinoma cell lines at the concentration of 100 μM, with induction of 41.5 ± 3.0 and 39.3 ± 2.3% cell death, respectively. Compounds 1‐5, 8 and 10 showed their inhibitory effect against NO overproduction in LPS‐stimulated RAW264.7 cells, with IC50 values ranging from 37.5 ± 2.6 to 86.5 ± 5.1 μM. Molecular docking simulation suggested that 1 inhibit NO overproduction via modulating the action of iNOS protein.

Lanostane triterpenoids from the fungus Physisporinus vitreus and their inhibitory activity against nitric oxide production

Physivitrins I-R, lanostane triterpenoids with anti-inflammatory activities from the fungus Physisporinus vitreus

Lanostane Triterpenoids from the Fruiting Bodies of Fomes Officinalis and Their Anti-Inflammatory Activities

Lanostane triterpenoids from the fruiting bodies of Fomitopsis pinicola and their anti-inflammatory activities

Triterpenes from the fungus Poria cocos and their inhibitory activity on nitric oxide production in mouse macrophages via blockade of activating protein-1 pathway

Anti-human immunodeficiency virus-1 protease activity of new lanostane-type triterpenoids from Ganoderma sinense.

Lanostane triterpenoids with anti-proliferative and anti-inflammatory activities from medicinal mushroom Ganoderma lingzhi

Lanostane Triterpenes Isolated from Antrodia Heteromorpha and Their Inhibitory Effects on Rankl-Induced Osteoclastogenesis

Three New Lanostane Triterpenoids and Two New Amides from Alternaria Sp. with NLRP3 Inflammasome Inhibitory Activity.

Anti-inflammatory lanostane triterpenoids with rearranged spirobi[indene] scaffold and their biogenetically related analogues from Euphorbia maculata

Actinofuranones D-I from a Lichen-Associated Actinomycetes, Streptomyces gramineus, and Their Anti-Inflammatory Effects

Highly Oxygenated Lanostane-Type Triterpenoids and Their Bioactivity from the Fruiting Body of Ganoderma Gibbosum

Metabolites with Anti-Inflammatory and Α-Glucosidase Inhibitory Activities from the Mangrove Endophytic Fungus Phoma Sp. SYSU-SK-7

Daphnane Diterpenoids with Nitric Oxide Inhibitory Activities and Interactions with Inos from the Leaves of Trigonostemon Thyrsoideus

Lanostane Triterpenes from the Tibetan Medicinal Mushroom Ganoderma leucocontextum and Their Inhibitory Effects on HMG-CoA Reductase and α-Glucosidase

Officimalonic Acids A−H, Lanostane Triterpenes from the Fruiting Bodies of Fomes Officinalis

An Oxazole Alkaloid, Terpenoids, and Cyclodipeptides with Cytotoxic and NO Inhibitory Effects from a Mangrove‐Derived Fungus Trichoderma sp. GXT‐22.1

Two New Lanostane-Type Triterpenoids from the Fungus Periconia Sp. TJ403-rc01.

Cytotoxic and anti-oxidant activities of lanostane-type triterpenes isolated from Poria cocos

Five New Furostanol Glycosides from the Fruits of Tribulus terrestris with NO Production Inhibitory Activity

New lanostane-type triterpenoids with proangiogenic activity from the fruiting body of Ganoderma applanatum